サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519749

合成生物学市場レポート：製品、技術、用途、地域別、2024年～2032年

Synthetic Biology Market Report by Product, Technology, Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
合成生物学市場レポート：製品、技術、用途、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

合成生物学の世界市場規模は2023年に160億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに620億米ドルに達し、2024年から2032年の間に15.9％の成長率（CAGR）を示すと予測しています。遺伝子編集技術における大幅な進歩、業界全体にわたる持続可能なソリューションに対する需要の高まり、協力的なエコシステム、ベンチャーキャピタル投資の増加は、市場を推進する主な要因の一部です。

合成生物学市場分析：

主な市場促進要因：世界の合成生物学市場は、遺伝子編集技術の向上により力強い成長を遂げています。

主な市場動向：学術界、産業界、政府間の協力的な取り組みにより、イノベーションと開発能力が強化されています。

地理的動向：バイオテクノロジーへの投資拡大により北米が市場を独占しています。しかし、アジア太平洋地域では研究活動や政府の取り組みが活発化しており、急成長市場として浮上しています。

競合情勢：主要企業は、技術革新を推進し、複雑な生物学的課題に対処するため、研究事業に投資しています。合成生物学業界の主な市場参入企業には、GenScript Biotech Corporation、Amyris Inc.、Ginkgo Bioworks、Mammoth Biosciences、Novozymes、Merck KGaAなどがあります。

課題と機会：課題としては、遺伝子組み換え製品に関する倫理的・安全的懸念が挙げられます。しかしながら、規制を遵守し、倫理的に配慮されたイノベーションを開発する市場開拓の機会は、こうした課題を克服するものと予測されます。

合成生物学市場動向／促進要因：

遺伝子編集技術の進歩

現在、CRISPR-Cas9のような様々な技術は、遺伝物質の正確かつ効率的な操作を可能にすることで生物学研究分野を向上させることができ、合成生物学市場の需要を強化しています。研究者たちは、極めて正確なDNA配列の設計、編集、操作を行っており、特定の機能に応じてカスタマイズされた複雑な合成生物の創造を容易にしています。この技術革新は、遺伝子治療による疾病治療や、酵素やバイオ燃料のような貴重な化合物を生産できる生物工学的生物の創出のような、新しい側面の開拓に新たな道を開き、市場拡大に貢献しています。さらに、世界保健機関（WHO）はヒトゲノム編集の世界ガバナンスに関する画期的な勧告を発表し、安全性、有効性、倫理性を強調しました。

持続可能なソリューションへの需要

さまざまな産業で持続可能で環境に優しいソリューションに対する需要の高まりが、合成生物学市場を後押ししています。合成生物学は、各業界が事業による環境への影響を減らすという要求を満たすためのさまざまな新しい道を提示しています。これに伴い、再生可能資源から抽出されたバイオプラスチックの生産や、持続可能性に向けた世界の動きと歩調を合わせた二酸化炭素排出量を削減したバイオ燃料の開拓が、市場の成長に寄与しています。これとは別に、合成生物学はバイオレメディエーション（汚染物質を無害化したり、環境を浄化したり、さまざまな緊急の生態学的合併症に対処したりする方法）のための微生物を作り出すことができます。さらに、合成生物学は美容分野の持続可能性への取り組みに革命を起こしています。ヴォーグ・ビジネス誌は、美容製品の20～40％が毎年廃棄物となり、リサイクル困難なパッケージが年間1,200億個も発生していると推定しています。さらに、化粧品原料の10種類のうち8種類は、持続不可能な方法で調達されています。こうした課題に対処するため、合成生物学は微生物のDNAを改変して持続可能な素材を作り出します。合成生物学市場の価格は、技術革新と多様な用途による急成長を反映しています。

共同エコシステムと投資

学術界、産業界、政府機関の連携による相乗効果により、合成生物学分野の研究活動に適した環境が醸成されています。共同研究は知識、資産、視点の交換を促進し、発明の速度を速める。政府当局は研究活動を支援するために助成金や資金を頻繁に提供し、既存企業と新興企業は市場の成長を促進する画期的なベンチャーのためにリソースを出し合う。これに加えて、バイオテクノロジー新興企業へのベンチャーキャピタル投資の急増は、この分野に重要な資本を注入し、萌芽的なアイデアを具体的な製品や合成生物学市場アプリケーションへと成長させる。この協力的なエコシステムは、研究、革新、商業化のサイクルを維持し、世界の合成生物学市場を前進させます。

さらに、合成生物学市場の未来は、比類のないイノベーション、持続可能なソリューション、そして広大な成長の可能性を約束します。Algal Bioのような企業は、多様な菌株を利用して斬新な解決策を革新し、Basecamp Researchのような新興企業は、機械学習（ML）を利用して合成タンパク質工学のための自然界の設計原理を解読しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の合成生物学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • オリゴヌクレオチド/オリゴプールと合成DNA
    • 市場動向
    • 市場予測
  • 酵素
    • 市場動向
    • 市場予測
  • クローニング技術キット
    • 市場動向
    • 市場予測
  • 異種核酸
    • 市場動向
    • 市場予測
  • シャーシ有機体
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • NGS技術
    • 市場動向
    • 市場予測
  • PCR技術
    • 市場動向
    • 市場予測
  • ゲノム編集技術
    • 市場動向
    • 市場予測
  • バイオプロセス技術
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • ヘルスケア
    • 市場動向
    • 主要セグメント
      • 臨床
      • 非臨床/調査
    • 市場予測
  • 非医療
    • 市場動向
    • 主要セグメント
      • バイオテクノロジー作物
      • 特殊化学品
      • バイオ燃料
      • その他
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Amyris Inc.
    • Codexis Inc.
    • Danaher Corporation
    • Eurofins Scientific
    • GenScript Biotech Corporation
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs
    • Synthego Corporation
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • Viridos Inc.
図表

List of Figures

  • Figure 1: Global: Synthetic Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Synthetic Biology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Synthetic Biology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Synthetic Biology Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Synthetic Biology Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Synthetic Biology Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Synthetic Biology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Synthetic Biology (Oligonucleotide/Oligo Pools and Synthetic DNA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Synthetic Biology (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Synthetic Biology (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Synthetic Biology (Cloning Technologies Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Synthetic Biology (Cloning Technologies Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Synthetic Biology (Xeno-nucleic Acids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Synthetic Biology (Xeno-nucleic Acids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Synthetic Biology (Chassis Organism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Synthetic Biology (Chassis Organism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Synthetic Biology (NGS Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Synthetic Biology (NGS Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Synthetic Biology (PCR Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Synthetic Biology (PCR Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Synthetic Biology (Genome Editing Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Synthetic Biology (Genome Editing Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Synthetic Biology (Bioprocessing Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Synthetic Biology (Bioprocessing Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Synthetic Biology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Synthetic Biology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Synthetic Biology (Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Synthetic Biology (Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Synthetic Biology (Non-Healthcare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Synthetic Biology (Non-Healthcare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Synthetic Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Synthetic Biology Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Synthetic Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Synthetic Biology Industry: SWOT Analysis
  • Figure 82: Global: Synthetic Biology Industry: Value Chain Analysis
  • Figure 83: Global: Synthetic Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Synthetic Biology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Synthetic Biology Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Synthetic Biology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Synthetic Biology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Synthetic Biology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Synthetic Biology Market: Competitive Structure
  • Table 7: Global: Synthetic Biology Market: Key Players
目次
Product Code: SR112024A5534

The global synthetic biology market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 62.0 Billion by 2032, exhibiting a growth rate (CAGR) of 15.9% during 2024-2032. Significant advancements in gene editing technologies, the rising demand for sustainable solutions across industries, collaborative ecosystems, and increasing venture capital investments are some of the major factors propelling the market.

Synthetic Biology Market Analysis:

Major Market Drivers: The global synthetic biology market is experiencing robust growth, driven by increasing improvements in gene editing technologies.

Key Market Trends: Collaborative efforts between academia, industry, and government are enhancing innovation and development capabilities.

Geographical Trends: North America dominates the market owing to the growing investments in biotechnology. However, Asia Pacific is emerging as a fast-growing market due to the increasing research activities and government initiatives in the region.

Competitive Landscape: Key players are investing in research operations to drive innovation and address complex biological challenges. Some of the major market players in the synthetic biology industry include GenScript Biotech Corporation, Amyris Inc., Ginkgo Bioworks, Mammoth Biosciences, Novozymes, Merck KGaA, among many others.

Challenges and Opportunities: Challenges include ethical and safety concerns related to genetically modified products. Nonetheless, opportunities for the market to develop regulatory-compliant, ethically considered innovations are projected to overcome these challenges.

Synthetic Biology Market Trends/Drivers:

Advancements in gene editing technologies

At present, various techniques like CRISPR-Cas9 are capable of improving the field of biology research by enabling precise and efficient manipulation of genetic material, strengthening the synthetic biology market demand. Researchers are designing, editing, and engineering DNA sequences with exceptional accuracy, facilitating the creation of intricate synthetic organisms customized according to specific functions. This innovation is opening new avenues for the development of novel aspects, like disease treatment through gene therapies and creation of bioengineered organisms capable of producing valuable compounds such as enzymes and biofuels, thus aiding in market expansion. Moreover, The World Health Organization (WHO) released groundbreaking recommendations for the global governance of human genome editing, emphasizing safety, efficacy, and ethics.

Demand for sustainable solutions

The rising demand for sustainable and environment-friendly solutions across various industries is propelling the synthetic biology market. Synthetic biology presents various new avenues for sectors to fulfill their demands to reduce the environmental impact of their operations. In line with this, the production of bioplastics extracted from renewable resources and the development of biofuels with reduced carbon emissions aligning with the global push towards sustainability are contributing to the market growth. Apart from this, synthetic biology is capable of creating microbes for bioremediation which is a method to detoxify contaminants or help clean up the environment and address various urgent ecological complications. Furthermore, synthetic biology is revolutionizing the sustainability efforts of the beauty sector. Vogue Business estimates that 20-40% of beauty products become waste annually, and the industry generates 120 billion units of difficult-to-recycle packaging yearly. Moreover, eight out of ten cosmetic ingredients are unsustainably sourced. To address these challenges, synthetic biology modifies microorganism DNA to create sustainable materials. The synthetic biology market price reflects rapid growth due to innovation and diverse applications.

Collaborative ecosystem and investment

The collaborative synergy between academia, industry, and government entities fosters a conducive environment for research operations within the synthetic biology field. Collaborations facilitate the exchange of knowledge, assets, and perspectives, thus quickening the rate of invention. Governing authorities frequently provide grants and funds to assist research endeavors, while established businesses and startups work together to pool resources for ground-breaking ventures that promote market growth. In addition to this, the surge in venture capital investments in biotechnology startups injects vital capital into the field, nurturing the growth of nascent ideas into tangible products and synthetic biology market application. This collaborative ecosystem sustains a cycle of research, innovation, and commercialization, propelling the global synthetic biology market forward.

Additionally, the future of the synthetic biology market promises unparalleled innovation, sustainability solutions, and expansive growth potential. Companies, such as Algal Bio utilize a diverse array of strains to innovate novel solutions, while startups like Basecamp Research employ machine learning (ML) to decipher the design principles of nature for synthetic protein engineering.

Synthetic Biology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global synthetic biology market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, and application.

Breakup by Product:

Oligonucleotide/Oligo Pools and Synthetic DNA

Enzymes

Cloning Technologies Kits

Xeno-nucleic Acids

Chassis Organism

Oligonucleotide/oligo pools and synthetic DNA dominates the market

The report has provided a detailed breakup and analysis of the market based on the product. This includes oligonucleotide/oligo pools and synthetic DNA, enzymes, cloning technologies kits, Xeno-nucleic acids, and chassis organism. According to the report, oligonucleotide/oligo pools and synthetic DNA represented the largest segment.

The growing demand for synthetic biology products, specifically oligonucleotide/oligo pools and synthetic DNA, is mainly fueled by the exponential growth in fields such as personalized medicine, gene therapy, and molecular diagnostics that have amplified the need for precise and customizable genetic materials. Additionally, the rise of synthetic biology startups and the democratization of gene editing technologies have made these products more accessible, empowering researchers across diverse disciplines to engage in innovative projects, thereby creating a favorable synthetic biology market outlook. For example, Synbio Technologies offers oligo pool synthesis for companies or clients who need to mass-produce short DNA strands, also known as oligonucleotides.

Breakup by Technology:

NGS Technology

PCR Technology

Genome Editing Technology

Bioprocessing Technology

Others

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes NGS, PCR, genome editing, bioprocessing, and other technologies.

Next-generation sequencing (NGS) technology has become instrumental in deciphering complex biological information, facilitating the analysis of vast genetic data sets, and accelerating the discovery of novel genetic components, which in turn, is presenting lucrative market opportunities. Moreover, polymerase chain reaction (PCR) technology remains a cornerstone for DNA amplification, crucial in generating sufficient genetic material for various applications, from research to diagnostics. Besides this, genome editing technologies, particularly CRISPR-Cas9, hold immense promise for precision genetic modifications, driving advancements in gene therapies and customized genetic engineering. Bioprocessing technologies form a critical facet, enabling efficient large-scale production of bioengineered compounds, ranging from pharmaceuticals to biofuels. Companies are also investing and focusing on these aspects to create novel technologies. For example, Bayer and Mammoth Biosciences collaborated to develop a novel gene editing technology to unlock the full potential of CRISPR systems.

Additionally, the synthetic biology market statistics highlight a robust growth trajectory, driven by advancements in biotechnology and increasing investment in research and development.

Breakup by Application:

Healthcare

Clinical

Non-Clinical/Research

Non-Healthcare

Biotech Crops

Specialty Chemicals

Bio-Fuels

Others

The report has provided a detailed breakup and analysis of the market based on the application. This includes healthcare (clinical and non-clinical/research) and non-healthcare (biotech crops, specialty chemicals, bio-fuels, and others).

The bolstering growth of the healthcare sector, wherein synthetic biology is used in the development of personalized medicines, gene therapies, and diagnostics, is contributing to the synthetic biology market growth. In addition, the numerous non-clinical or research applications of synthetic biology encompassing drug discovery, functional genomics, and biomolecule production, are fueling scientific exploration and market growth. Beyond healthcare, synthetic biology's expanding usage in biotech crops engineered for improved yield and resistance to pests is positively influencing the market. Furthermore, the increasing product adoption across the specialty chemicals industry, wherein bioengineered pathways create sustainable routes to produce high-value compounds is impelling the market growth. Apart from this, the growing use of synthetic biology in the biofuel sector to optimize microorganisms for efficient biofuel production is strengthening the market growth. Key market players are focusing on collaborating with each other to develop various novel technologies in synthetic biology. For instance, scientists led by Gerard Wright at McMaster University developed a synthetic biology platform for novel glycopeptide antibiotics (GPA) discovery. They engineered Streptomyces coelicolor as a chassis for GPA biosynthesis, overcoming challenges in cloning large biosynthetic gene clusters (BGCs) using an optimized transformation-associated recombination (TAR) system. The platform enabled the synthesis of corbomycin and the discovery of novel GPAs, expanding antibiotic candidates' repertoire.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest synthetic biology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The presence of a well-established research and innovation ecosystem in North America, characterized by leading academic institutions, cutting-edge biotechnology companies, and significant government investments, provides a fertile ground for advancements in synthetic biology. Moreover, the region's emphasis on R&D and technological innovation fosters collaborations that span academia and industry, driving the development of novel applications across sectors including healthcare, agriculture, and energy. In addition to this, the increasing focus on sustainable solutions and the demand for eco-friendly products align with synthetic biology's potential to offer greener alternatives. This, coupled with favorable regulatory frameworks that encourage biotechnology R&D, creates an environment conducive to the expansion of the North American synthetic biology market. In December 2022, the Investment Strategy by the Office of Strategic Capital (OSC) identifies synthetic biology as a priority technology area for private sector investment, aiming to attract capital and foster innovation in this field for national security purposes. The synthetic biology market overview reveals its rapid expansion, driven by innovation, research investment, and diverse applications.

Competitive Landscape:

The global synthetic biology market features a dynamic competitive landscape shaped by a blend of established players and innovative startups. Leading companies, with their significant financial resources and expansive research capabilities, dominate the market by offering a diverse range of synthetic biology products and services and highlighting how big is the synthetic biology market? These companies actively engage in collaborations, strategic partnerships, and mergers to enhance their offerings and expand their market reach. Furthermore, a surge in venture capital investments has catalyzed the emergence of agile startups, injecting fresh ideas and disruptive technologies into the field. The competitive arena is characterized by a focus on innovation, technology integration, and the ability to address diverse market segments, accentuating the evolutionary nature of the global synthetic biology market. On of the key players, Eurofins Genomics Blue Heron, introduced its IVT mRNA Synthesis Service, using cutting-edge technology for rapid and efficient mRNA transcript production. Tailored for various fields including molecular biology and gene therapy, it offers customizable synthesis with quick turnaround times and expert support, benefiting synthetic biology research and applications. According to synthetic biology market recent news, Aanika Biosciences is revolutionizing synthetic biology adoption across industries like food and agriculture through insurance. Their subsidiary, Aanika Insurance Services (AIS), offers cost-effective coverage, encouraging biologic use while ensuring risk mitigation and frequent sampling. Partnering with Western Growers Insurance Services, Aanika aims to expand its reach to farmers, distributors, and retailers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Amyris Inc.

Codexis Inc.

Danaher Corporation

Eurofins Scientific

GenScript Biotech Corporation

Illumina Inc.

Merck KGaA

New England Biolabs

Synthego Corporation

Thermo Fisher Scientific Inc.

Twist Bioscience

Viridos Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In May 2023, GenScript Biotech Corporation launched GenTitan(TM) Gene Fragments synthesis service, a commercial miniature semiconductor platform that utilizes integrated circuits for high-throughput DNA synthesis.

In May 2023, Codexis, Inc. unveiled Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis(TM) technology, a proprietary new synthesis platform being developed for manufacturing RNA oligonucleotide therapeutics at scale.

In January 2023, Agilent Technologies partnered with Akoya Biosciences to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the clinical research market.

Key Questions Answered in This Report:

  • How has the global synthetic biology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global synthetic biology market?
  • What is the impact of each driver, restraint, and opportunity on the global synthetic biology market?
  • What are the key regional markets?
  • Which countries represent the most attractive synthetic biology market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the synthetic biology market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the synthetic biology market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the synthetic biology market?
  • What is the competitive structure of the global synthetic biology market?
  • Who are the key players/companies in the global synthetic biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Synthetic Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oligonucleotide/Oligo Pools and Synthetic DNA
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Enzymes
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cloning Technologies Kits
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Xeno-nucleic Acids
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Chassis Organism
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 NGS Technology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 PCR Technology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Genome Editing Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Bioprocessing Technology
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Clinical
      • 8.1.2.2 Non-Clinical/Research
    • 8.1.3 Market Forecast
  • 8.2 Non-Healthcare
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Biotech Crops
      • 8.2.2.2 Specialty Chemicals
      • 8.2.2.3 Bio-Fuels
      • 8.2.2.4 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amyris Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Codexis Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GenScript Biotech Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Illumina Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 New England Biolabs
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Synthego Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Twist Bioscience
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Viridos Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio